Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Leukemia, Myeloid, Acute 89Precursor Cell Lymphoblastic Leukemia-Lymphoma 80Leukemia 75Myelodysplastic Syndromes 72Leukemia, Lymphocytic, Chronic, B-Cell 67Lymphoma, Non-Hodgkin 66Multiple Myeloma 58Hodgkin Disease 54Lymphoma, Mantle-Cell 53Lymphoma, Large B-Cell, Diffuse 50Lymphoma, Follicular 49Leukemia, Myeloid, Chronic-Phase 48Lymphoma 44Lymphoma, B-Cell, Marginal Zone 43Burkitt Lymphoma 43Myeloproliferative Disorders 41Lymphoma, Large-Cell, Immunoblastic 39Leukemia, Myelomonocytic, Chronic 38Leukemia, Myeloid, Accelerated Phase 38Congenital Abnormalities 37Anemia, Refractory, with Excess of Blasts 33Leukemia, Myelogenous, Chronic, BCR-ABL Positive 30Dendritic Cell Sarcoma, Interdigitating 30Blast Crisis 30Recurrence 29Graft vs Host Disease 29Primary Myelofibrosis 25Waldenstrom Macroglobulinemia 23Myelodysplastic-Myeloproliferative Diseases 22Lymphoma, T-Cell, Cutaneous 22

Interventions

Carboplatin 88pembrolizumab 85Paclitaxel 71Cyclophosphamide 63Capecitabine 38Doxorubicin 37Taxes 29130-nm albumin-bound paclitaxel 29Cisplatin 25Albumin-Bound Paclitaxel 22Epirubicin 21Drug Therapy 21Docetaxel 20sacituzumab govitecan 19olaparib 19camrelizumab 18atezolizumab 18Gemcitabine 17eribulin 16durvalumab 16Bevacizumab 16Radiotherapy 15toripalimab 14Specimen Handling 14Biopsy 13Everolimus 12Magnetic Resonance Spectroscopy 11apatinib 10Nivolumab 10talazoparib 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Triple Negative Breast Neoplasms × Cyclosporine × Clear all
NCT06246786 2025-07-16

Breast/Cyclosporin A/TNBC (Triple Negative Breast Cancer)

The University of Texas Health Science Center at San Antonio

Phase EARLY_PHASE1 Withdrawn
Breast

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡